One of the antecedent processes to drug giving or drug taking is an action (promotion) by pharmaceutical companies to influence these behaviors. In most countries, especially Third World countries, the promotional material is a primary source of drug information to practitioners. When this material is intentionally biased or is accompanied by other unethical practices, company ethics are rightly questioned.
Third World pharmaceutical promotional practices are examined, along with some of the consequences that occur as a result of the discovered improprieties. Several factors that impact on public's view of the pharmaceutical industry are discussed as well as their influence on member firm's reputation. The more that a company understands these factors and incorporates this knowledge into their strategic planning, the greater will be its potential for long-term growth and sustained profitability.
Get full access to this article
View all access options for this article.
References
1.
BarkanIlyse D.1985Industry Invites Regulation: The Passage of the Pure Food and Drug Act of 1906. American Journal of Public Health75(1):18–25.
2.
CampbellCarolyn E.1982The Decline in Breast Feeding: An Analysis of the Role Nestle Corporation From Two Perspectives. Cornell International Nutrition Monograph Series (#11), Ithaca, NY: Cornell Univ. Press.
3.
ClouseEdward H.1987The Role of Drug Therapy in Alternative Healing Systems. Journal of Drug Issues17(4):.
4.
DickinsonJ. G.1985Consumer Panel Condemns Drug Industry. Dickinson's FDA1 (4):1.
5.
Editorial1982The Influence of Drug Advertisements. Lancet (2):1257.
6.
Federal Food, Drug and Cosmetic Act1938 21 USC § 355(d) (5) and (6).
7.
Franco-AgudeloSaul1983The Rockefeller Foundation's Antimalarial Program in Latin America: Donating or Dominating?International Journal of Health Services13(1):51–67.
8.
GagnonJean Paul1983Physician Prescribing Habits. Principles of Pharmaceutical Marketing, 3rd Edition, SmithM. C. (ed.). Philadelphia: Lea & Febiger.
9.
GosselinRay1962Pharmaceutical Marketing Research, Speech presented at the University of Texas, February 20.
10.
Haslemere Group1976Who Needs the Drug Companies?War on Want and Third World First. London: Haslemere Group.
11.
HellerT.1976Poor Health, Rich Profits: Multinational Drug Companies and the Third World. London: Spokesman Books.
12.
HemminkiE.1975The Role of Prescriptions in Therapy. Medical Care13(2):150–159.
13.
KleinTed1983Detailing and Other Forms of Promotion. Principles of Pharmaceutical Marketing, 3rd Edition, SmithM. C. (ed.). Philadelphia: Lea & Febiger.
14.
LallS.1975Major Issues in Transfer of Technology to Developing Countries: A Case Study of the Pharmaceutical Industry. U.N. Conference on Trade & Development, Geneva.
15.
LaPorteJoan-Romon1984Drugs in the Spanish Health System. International Journal of Health Services14(4):635–647.
16.
LedogarR. J.1975Hungry for Profits: U.S. Food and Drug Multinationals in Latin America. New York: TDOC/North America.
17.
MacSheoinTomas1986Unethical Behavior in an Ethical Industry? Critical Coverage of the Pharmaceutical Industry, 1983–1984. International Journal of Health Services16(1):141–162.
18.
MedawarC.1979Insult or Injury? An Enquiry into the Marketing and Advertising of British Food and Drug Products in the Third World. London: Social Audit Ltd.
19.
Medical Sociology Research Centre1976Prescribing in General Practice. Journal of the Royal College of General Practitioners26(1):58–64.
20.
MelvilleA.JohnsonC.1982Cured to Death: The Effects of Prescription Drugs. New York: Stern and Day.
21.
MillerDuffy1986Pharmaceutical Manufacturer's Association Newsletter, MillerDuffy (ed.). 28 (44):1.
MintzM.1985At Any Cost: Corporate Greed, Women, and the Dalkon Shield. New York: Pantheon.
24.
MontagneMichaelBleidtBarry1987Social Forces in the Premature Removal of Drug Products From the Marketplace. Clinical Research Practices and Drug Regulatory Affairs5(2/3):83–129.
25.
MullerM.1977Selling Health— or Buying Favour?New Scientist (2):266–268.
26.
Roper Organization1987Changing Buying Habits. U.S.A. Today, January 28.
27.
SilvermanMiltonLeePhilip1974Pills, Profits and Politics. Berkeley: University of California Press.
28.
SilvermanMilton1976The Drugging of the Americas. Berkeley: University of California Press.
29.
SilvermanMilton1977Epidemiology of Drug Promotion. International Journal of Health Services7(2): 157–166.
30.
SilvermanMiltonLeePhilip R.LydeckerMia1982aPrescriptions for Death: The Drugging of the Third World. Berkeley: University of California Press.
31.
SilvermanMiltonLeePhilip R.LydeckerMia1982bThe Drugging of the Third World. International Journal of Health Services12(4):585–596.
32.
SilvermanMiltonLeePhilip R.LydeckerMia1986Drug Promotion: The Third World Revisited. International Journal of Health Services16(4):659–667.
33.
SmithMickey C.1975Principles of Pharmaceutical Marketing, 2nd Ed.Philadelphia: Lea & Febiger.
34.
SmithMickey C.1983Principles of Pharmaceutical Marketing, 3rd Ed.Philadelphia: Lea & Febiger.
35.
TognaniG.1982Drug Use and Monitoring. Evaluation of Health Care. HollandW.BennetW. (eds.). New York: Oxford University Press.
36.
WilkersonGary C.PietrangeloMichael A.1983External Controls. Principles of Pharmaceutical Marketing, 3rd Ed.SmithM. C. (ed.). Philadelphia: Lea & Febiger.
37.
YudkinJohn S.1980The Economics of Pharmaceutical Supply in Tanzania. International Journal of Health Services10(3):455–477.
